Evaluation of a clinical score for predicting atrial fibrillation in cryptogenic stroke patients with insertable cardiac monitors: results from the CRYSTAL AF study
- PMID: 31007721
- PMCID: PMC6460885
- DOI: 10.1177/1756286419842698
Evaluation of a clinical score for predicting atrial fibrillation in cryptogenic stroke patients with insertable cardiac monitors: results from the CRYSTAL AF study
Abstract
Background: The HAVOC score was previously developed to predict the risk of atrial fibrillation (AF) after cryptogenic stroke (CS) or transient ischemic attack (TIA). The purpose of this study was to apply the HAVOC score to patients who received insertable cardiac monitors (ICMs) in the CRYSTAL AF study.
Methods: All patients from the CRYSTAL AF study who received an ICM were included. HAVOC score (one point each for peripheral vascular disease and obesity with body mass index >30, two points each for hypertension, age ⩾ 75, valvular heart disease, and coronary artery disease, 4 points for congestive heart failure) was computed for all patients. The primary endpoint was AF detection by 12 months of ICM monitoring.
Results: A total of 214 patients who received ICM were included. AF was detected in 40 patients while the remaining 174 patients were AF negative. The HAVOC score was significantly higher among patients with AF [median 3.0 with interquartile range (IQR) 2-4] than those without AF [median 2.0 (IQR 0-3)], p = 0.01. AF increased significantly across the three HAVOC score groups: 11% in Group A (score 0-1), 18% in Group B (score 2-3), and 32 % in Group C (score ⩾ 4) with p = 0.02.
Conclusions: The HAVOC score was shown in this post hoc analysis of CRYSTAL AF to successfully stratify AF risk post CS or TIA. The 11% AF rate in the lowest HAVOC score group highlights the significance of nontraditional contributors to AF and ischemic stroke.
Keywords: atrial fibrillation; cryptogenic stroke; insertable cardiac monitor; risk stratification; transient ischemic attack.
Conflict of interest statement
Conflict of interest statement: PDZ and JLK are employees and shareholders of Medtronic, Inc. RSP reports speaker fees from Medtronic and Biotronik. SXZ, CK, and MHC report no relationships relevant to the contents of this paper to disclose.
Figures



Similar articles
-
Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial Fibrillation.Cardiology. 2021;146(5):633-640. doi: 10.1159/000517827. Epub 2021 Jun 22. Cardiology. 2021. PMID: 34157712
-
Insertable cardiac monitors after cryptogenic stroke--a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation.Eur J Neurol. 2016 Feb;23(2):375-81. doi: 10.1111/ene.12843. Epub 2015 Oct 16. Eur J Neurol. 2016. PMID: 26470854
-
Value of HAVOC and Brown ESUS-AF scores for atrial fibrillation on implantable cardiac monitors after embolic stroke of undetermined source.J Stroke Cerebrovasc Dis. 2024 Jan;33(1):107451. doi: 10.1016/j.jstrokecerebrovasdis.2023.107451. Epub 2023 Nov 22. J Stroke Cerebrovasc Dis. 2024. PMID: 37995501 Review.
-
A Clinical Score for Predicting Atrial Fibrillation in Patients with Cryptogenic Stroke or Transient Ischemic Attack.Cardiology. 2017;138(3):133-140. doi: 10.1159/000476030. Epub 2017 Jun 28. Cardiology. 2017. PMID: 28654919 Free PMC article.
-
A Comprehensive Review of Cryptogenic Stroke and Atrial Fibrillation: Real-World Insights Into the Role of Insertable Cardiac Monitors.Cureus. 2024 Sep 28;16(9):e70369. doi: 10.7759/cureus.70369. eCollection 2024 Sep. Cureus. 2024. PMID: 39469374 Free PMC article. Review.
Cited by
-
Risk scores for prediction of paroxysmal atrial fibrillation after acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis.Int J Cardiol Cardiovasc Risk Prev. 2024 Feb 23;21:200249. doi: 10.1016/j.ijcrp.2024.200249. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 38496328 Free PMC article. Review.
-
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA.Europace. 2022 Dec 9;24(12):1881-1888. doi: 10.1093/europace/euac092. Europace. 2022. PMID: 35819199 Free PMC article.
-
Left Ventricular Diastolic Dysfunction with Elevated Filling Pressures Is Associated with Embolic Stroke of Undetermined Source and Atrial Fibrillation.Tomography. 2024 Oct 14;10(10):1694-1705. doi: 10.3390/tomography10100124. Tomography. 2024. PMID: 39453041 Free PMC article.
-
Cryptogenic stroke as a working diagnosis: the need for an early and comprehensive diagnostic work-up.BMC Neurol. 2023 Apr 14;23(1):153. doi: 10.1186/s12883-023-03206-6. BMC Neurol. 2023. PMID: 37060045 Free PMC article.
-
Risk Stratification Tools to Guide a Personalized Approach for Cardiac Monitoring in Embolic Stroke of Undetermined Source.J Am Heart Assoc. 2023 Sep 19;12(18):e030479. doi: 10.1161/JAHA.123.030479. Epub 2023 Sep 8. J Am Heart Assoc. 2023. PMID: 37681521 Free PMC article.
References
-
- Yaghi S, Bernstein RA, Passman R, et al. Cryptogenic stroke: research and practice. Circ Res 2017; 120: 527–540. - PubMed
-
- Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478–2486. - PubMed
-
- Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370: 2467–2477. - PubMed
-
- Christensen LM, Krieger DW, Højberg S, et al. Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the SURPRISE study. Eur J Neurol 2014; 21: 884–889. - PubMed